Onelife Capital Advisors Gains Approval for Rights Issue Share Listing

Onelife Capital Advisors Limited has secured final approval from the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) to list equity shares from its recent rights issue. Trading for these 2.40 crore shares is scheduled to commence on March 25, 2026.

Rights Issue Details

The company will list a total of 2,40,00,000 equity shares. These shares were offered at an issue price of ₹15 each, with a face value of ₹10, as part of a rights issue that raised ₹36 crore.

Fund Use and Financial Context

Funds raised from the ₹36 crore rights issue are primarily allocated to bolster its subsidiary, Dealmoney Commodities Private Limited, with ₹27 crore designated for margin money requirements. The remaining funds will be used for general corporate purposes. This capital infusion follows a period of financial strain, during which the company reported a net loss of ₹487.81 lakhs in FY25 and a negative Earnings Per Share (EPS) of ₹(3.65). This contrasts with its financial performance in FY24. Onelife Capital Advisors also conducted a previous rights issue on December 10, 2025, priced at ₹10 per share.

Impact of New Shares on the Market

The listing approval means the 2.40 crore newly issued equity shares will become actively traded on the BSE and NSE starting March 25, 2026. This will increase the total number of outstanding shares, potentially leading to dilution for existing shareholders who did not participate in the rights issue. Increased trading volume is anticipated, which could improve the stock's liquidity.

Key Risks to Monitor

Several factors warrant attention. Trading of the shares is contingent on the company confirming that shares have been credited to beneficiary accounts via depositories. Significant past regulatory issues persist, including SEBI's prior restraint on Onelife Capital Advisors and its promoters from participating in securities markets due to alleged fund diversion and misrepresentation. Criticisms of internal oversight failures have also been noted.

Furthermore, the company's recent financial performance presents ongoing concerns, with a net loss in FY25, negative EPS, and negative Return on Net Worth (RoNW).

Peer Comparison

Operating in the financial services sector, Onelife Capital Advisors is positioned alongside larger entities such as Edelweiss Financial Services, IIFL Finance, and Cholamandalam Investment and Finance Company. While these peers typically manage substantial assets and often focus on diverse retail lending with robust governance, Onelife Capital faces distinct challenges, including recent financial losses and significant regulatory scrutiny from SEBI, indicating a different risk profile.

Contextual Metrics

The company's paid-up equity share capital saw an increase from ₹13.36 crore to ₹37.36 crore following the rights issue allotment on March 17, 2026. The rights issue itself recorded a subscription percentage of 103.21% as of March 24, 2026.

What to Track Next

Investors will be watching for confirmation of the trading commencement on BSE and NSE on March 25, 2026, and the subsequent market reaction. Future financial results, particularly the company's ability to return to profitability, will be critical. Updates regarding the SEBI investigations and restrictions on the company and its promoters, as well as the utilization of funds from the rights issue and their impact on subsidiary operations, will also be important to follow.